NEW YORK, Jan. 27, 2017 -- PHI Group, a U.S. public company focusing on acquisitions and investments in special situations (www.phiglobal.com) (OTCMarkets:PHIL), has signed a Memorandum of Agreement to acquire a minimum of 51% interest in Hoang Minh Chau Hung Yen LLC, a Vietnamese company located in Chi Tan Village, Khoai Chau District, Hung Yen Province, Vietnam (“HMC”), that specializes in cultivating and processing of turmeric (curcuma longa).
According to the agreement, the Company will pay a combination of cash and stock in exchange for a majority interest in HMC. The acquisition is part of the Company’s plan to apply the proprietary enhanced bioavailable nutrients and natural symbiotic immune system to grow organic turmeric in Hung Yen Province, Vietnam and at the same time utilize HMC’s expertise and experience to grow premium organic turmeric in the U.S. for Abundant Farms, a PHI Group’s agricultural subsidiary.
HMC grows turmeric and buys harvested crops from other local farmers for its turmeric processing plant. It produces turmeric powder for food, healthcare and beauty supply and also contracts with the Vietnamese Institute of Industrial Chemistry to process curcuminoids from turmeric for various usages.
According to www.webmd.com, turmeric can be used for arthritis, heartburn (dyspepsia), joint pain, stomach pain, Crohn's disease and ulcerative colitis, bypass surgery, hemorrhage, diarrhea, intestinal gas, stomach bloating, loss of appetite, jaundice, liver problems, Helicobacter pylori (H. pylori) infection, stomach ulcers, irritable bowel syndrome (IBS), gallbladder disorders, high cholesterol, a skin condition called lichen planus, skin inflammation from radiation treatment and fatigue and a variety of other ailments.
In food and manufacturing, the essential oil of turmeric is used in perfumes. Its resin is used as a flavor and color component in foods.
http://www.webmd.com/vitamins-supplements/ingredientmono-662-turmeric.aspx?activeingredientid=662
Dong Quang Hoang, Director of HMC stated: “We look forward to working with PHI Group to utilize its enhanced bioavailable nutrients and natural symbiotic immune system to grow premium organic turmeric in Hung Yen Province to provide better quality and yields for our turmeric crops.”
Henry Fahman, Chairman and CEO of PHI Group, said: “Since traditional turmeric rhizomes in Chi Tan Village, Hung Yen Province are among the very best in the world in terms of size and curcumin contents, we believe PHI Group’s Abundant Farms can greatly benefit from using these seed roots and HMC’s expertise and experience in our turmeric farming program.”
About PHI Group
Founded in 1982, PHI Group primarily focuses on acquisitions as a principal and invests in special situations in large, growing markets that may substantially enhance shareholder value.
About Hoang Minh Chau Hung Yen Co.
Hoang Minh Chau Hung Yen LLC, recognized among the top 100 leading brands in Vietnam, specializes in cultivating and processing of turmeric. http://hoangminhchauhungyen.com/
Safe Harbor:
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995.
Contact: Henry Fahman +1-702-475-5430 [email protected]


Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Italy Fines Apple €98.6 Million Over App Store Dominance
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FDA Approves Mitapivat for Anemia in Thalassemia Patients
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 



